Related Experiment Video
Updated: Jul 15, 2026
08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Optimized Lipid Nanoparticles with Tail-Modified Ionizable Lipids for Safer mRNA Delivery.
Seo-Hyeon Bae1,2, Jisun Lee1, Jae-Hun Ahn3
1Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon, Gyeonggi-do, Republic of Korea.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|July 14, 2026
Summary
Researchers developed new ionizable lipids for lipid nanoparticles (LNPs) to improve mRNA therapeutics. Tailored hydrophobic tails enhance LNP delivery, reducing toxicity and boosting efficacy for safer vaccines and treatments.
Area of Science:
- Biochemistry
- Drug Delivery
- Nanotechnology
Background:
- Lipid nanoparticles (LNPs) are crucial for mRNA therapeutics.
- Current ionizable lipids face limitations like dose-limiting toxicity and suboptimal efficiency.
- Hydrophobic tail chemistry is suspected but lacks systematic structure-activity relationship (SAR) analysis.
Purpose of the Study:
- To conduct a systematic SAR analysis of tail-modified ionizable lipids.
- To identify molecular design principles for next-generation LNPs.
- To develop safer and more effective mRNA-based vaccines and therapeutics.
Main Methods:
- Synthesized a 56-member library of tail-modified ionizable lipids.
- Incorporated biodegradable disulfide linkages, varied chain length, and branching in hydrophobic tails.
- Performed systematic SAR evaluation of lipid performance.
Main Results:
- Hydrophobic tail architecture critically influences endosomal escape, biocompatibility, and mRNA translation.
- Optimized LNPs demonstrated potent mRNA delivery efficacy.
- Reduced cytotoxicity, lower cytokine induction, and balanced immune activation were observed in nonhuman primates.
Conclusions:
- Established the first comprehensive SAR framework linking tail chemistry to ionizable lipid function.
- Provided molecular design principles for advanced LNPs.
- Paved the way for developing safer and more effective mRNA vaccines and therapeutics.
